Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study
- PMID: 19220775
- DOI: 10.1111/j.1399-3038.2008.00827.x
Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study
Abstract
It is estimated that at least one out of three children with recurrent wheezing is atopic. Reliable diagnostic tools are needed in primary care that allow for adequate identification of these children. The purpose of this study was to assess the value of ImmunoCAP Rapid (ICR) Wheeze-Rhinitis Child in the identification of atopy with the use of 10 selected allergens in children with recurrent episodes of wheezing. A multicenter population study is based on primary care. It included children managed consecutively at the health center, who had three or more episodes of wheezing, at least one of them in the last 12 months. Each child completed a physical examination, an epidemiological survey, one capillary blood sampling (110 microl) for ICR, and one venous blood sampling for determination of Phadiatop Infant, total IgE and 10 specific IgE measurements. The children were identified as atopic, based on their clinical signs and symptoms and at least one positive specific IgE (0.35 kU(A)/l or higher), before knowing the results of ICR, Phadiatop Infant and total IgE. ICR was read by two independent observers. Six classes were evaluated, negative without any color and five positive degrees of pink-red color. Two hundred and fifteen children aged between 1 and 14 years were studied (138 boys); 50.7% were identified as atopic, 39.1% were sensitized only to inhalant allergens, 6.5% to food allergens and 5.1% to both. The predominant allergen was the dust mite (39.3%). For ICR, there were 2134 valid double observations. The Kappa index, comparing the negative results vs. any positive result, was 0.91 (95% CI: 0.88-0.94). The intraclass correlation coefficient was 0.98 (95% CI: 0.98-0.99). In the identification of a child as atopic, the positive post-test probability of ICR depended on the color degrees considered: 88.4% for any positive and 97.6% for the most intense tones. The positive post-test probability of Phadiatop Infant and total IgE was 95.6% and 68.2% respectively. ICR showed good reliability for the most prevalent allergen, the dust mite, with a sensitivity of 90.5% (95% CI: 82.1-95.8) and specificity of 88.5% (95% CI: 81.7-93.4). The analysis of the other allergens was limited by the small number of sensitized children. The analysis of receiver operating characteristic curves revealed an area under the curve of 0.84 (95% CI 0.80-0.88) for the cut-off point of specific IgE of 0.35 kU(A)/l and of 0.94(CI 0.91-0.97) for 2 kU(A)/l. A greater intensity of color of the lines of ICR was related to higher levels of specific IgE in blood. ICR is a reliable test for the identification of atopy in children, which identifies most children as atopic, and shows a good correlation in allergen-by-allergen identification. This suggests that it should be regarded as a first-rate tool, in the primary care clinic, for the evaluation of children with recurrent wheezing.
Similar articles
-
Differential diagnosis of IgE-mediated allergy in young children with wheezing or eczema symptoms using a single blood test.Ann Allergy Asthma Immunol. 2004 Oct;93(4):328-33. doi: 10.1016/S1081-1206(10)61390-7. Ann Allergy Asthma Immunol. 2004. PMID: 15521367
-
ImmunoCAP Phadiatop Infant--a new blood test for detecting IgE sensitisation in children at 2 years of age.Allergy. 2006 Mar;61(3):337-43. doi: 10.1111/j.1398-9995.2005.00936.x. Allergy. 2006. PMID: 16436143
-
The ImmunoCAP Rapid Wheeze/Rhinitis Child test is useful in the initial allergy diagnosis of children with respiratory symptoms.Pediatr Allergy Immunol. 2009 Dec;20(8):772-9. doi: 10.1111/j.1399-3038.2009.00866.x. Epub 2009 Jun 22. Pediatr Allergy Immunol. 2009. PMID: 19549098
-
Diagnostic reliability considerations of specific IgE determination.J Investig Allergol Clin Immunol. 1996 May-Jun;6(3):152-61. J Investig Allergol Clin Immunol. 1996. PMID: 8807505 Review.
-
Clinical laboratory assessment of immediate-type hypersensitivity.J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S284-96. doi: 10.1016/j.jaci.2009.09.055. J Allergy Clin Immunol. 2010. PMID: 20176264 Review.
Cited by
-
Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage.PLoS One. 2015 Oct 6;10(10):e0139945. doi: 10.1371/journal.pone.0139945. eCollection 2015. PLoS One. 2015. PMID: 26439628 Free PMC article.
-
Asthma outcomes: biomarkers.J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9-23. doi: 10.1016/j.jaci.2011.12.979. J Allergy Clin Immunol. 2012. PMID: 22386512 Free PMC article. Review.
-
Allergy Diagnosis in Children and Adults: Performance of a New Point-of-Care Device, ImmunoCAP Rapid.World Allergy Organ J. 2009 Jul;2(7):138-43. doi: 10.1097/WOX.0b013e3181aed85c. World Allergy Organ J. 2009. PMID: 23283063 Free PMC article.
-
The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery.Arch Toxicol. 2014 Jul;88(7):1391-417. doi: 10.1007/s00204-014-1245-3. Epub 2014 Jun 4. Arch Toxicol. 2014. PMID: 24894431 Free PMC article. Review.
-
The golden age: gold nanoparticles for biomedicine.Chem Soc Rev. 2012 Apr 7;41(7):2740-79. doi: 10.1039/c1cs15237h. Epub 2011 Nov 22. Chem Soc Rev. 2012. PMID: 22109657 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources